May 11, 2023
On April 21, 2023, the selection of participants in the clinical trial of the Diabfrail Latam project concluded. Thanks to the work of the Latin American partners from Colombia, Peru, Chile and Mexico, we finally have a total of 712 participating subjects. We think...
Ene 27, 2023
The team from the Pontificia Universidad Javeriana of Bogotá, led by Doctor Carlos Cano, has achieved a new milestone in the DIABFRAIL-LATAM project by recruiting subject number 350 to participate in the study. For its part, the research team in Requínoa under the...
Ene 27, 2023
El equipo de la Pontificia Universidad Javeriana de Bogotá, dirigido por el Doctor Carlos Cano, ha logrado un nuevo hito en el proyecto DIABFRAIL-LATAM al reclutar al sujeto número 350 para participar en el estudio. Por su parte, el equipo investigador en Requínoa...
Sep 21, 2022
Within the framework of the project financed with funds from the European Union, Diabfrail Latam, which is being developed in 4 Latin American countries (Colombia, Peru, Chile and Mexico) and two European countries (Spain and Italy), the municipality of Requínoa in...
Sep 21, 2022
and the excerpt of the interview in which participation in the Diabfrail Latam project is offered:
Comentarios recientes